SIGNIFICANCE OF DETERMINING ANTIBODIES TO ACETYLCHOLINE-RECEPTOR IN MYASTHENIA-GRAVIS

被引:40
|
作者
TOYKA, KV
BECKER, T
FATEHMOGHADAM, A
BESINGER, UA
BREHM, G
NEUMEIER, D
HEININGER, K
BIRNBERGER, KL
机构
[1] UNIV MUNICH,KLINIKUM GROSSHADERN,INST KLIN CHEM,D-8000 MUNICH 70,FED REP GER
[2] UNIV MUNICH,KLINIKUM GROSSHADERN,MED KLIN 3,D-8000 MUNICH 70,FED REP GER
来源
KLINISCHE WOCHENSCHRIFT | 1979年 / 57卷 / 18期
关键词
Acetylcholine-receptor; Acetylcholine-receptor antibodies; Autoimmune disease; Myasthenia gravis; Plasmapheresis;
D O I
10.1007/BF01478550
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The sera of 65 patients with myasthenia gravis (MG) were analysed for antibodies against the nicotinic acetylcholine receptor (ACh-R) using an immunoprecipitation assay (125I-α-bungarotoxin bound to human ACh-R as antigen). In 91% of MG sera elevated antibody titers were found ranging up to 500 times reference values. A control group of 77 patients showing various autoimmunological phenomena had ACh-R antibody concentrations within the reference range. The demonstration of antibodies against ACh-R provides a sensitive and highly specific tool for the diagnosis of MG. In addition, the test is helpful in following patients under treatment with immunosuppressive drugs or plasmapheresis. Antibodies against striated, smooth, or heart muscle (indirect immunofluorescence test) are much less sensitive and nonspecific for the diagnosis of MG. © 1979 Springer-Verlag.
引用
收藏
页码:937 / 942
页数:6
相关论文
共 50 条
  • [41] MYASTHENIA-GRAVIS AND SCLERODERMA
    BHALLA, R
    SWEDLER, WI
    LAZAREVIC, MB
    AJMANI, HS
    SKOSEY, JL
    JOURNAL OF RHEUMATOLOGY, 1993, 20 (08) : 1409 - 1410
  • [42] OCULAR MYASTHENIA-GRAVIS
    MARCH, GA
    JOHNSON, LN
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 1993, 85 (09) : 681 - 684
  • [43] ANXIETY IN MYASTHENIA-GRAVIS
    ROHR, W
    PSYCHOTHERAPIE PSYCHOSOMATIK MEDIZINISCHE PSYCHOLOGIE, 1993, 43 (3-4) : 93 - 99
  • [44] An update of the pharmacological treatment options for generalized myasthenia gravis in adults with anti-acetylcholine receptor antibodies
    Riley, Tanya R.
    Douglas, Janine S.
    Wang, Christopher
    Bowser, Kiarra M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2023, 80 (11) : 652 - 662
  • [45] MYASTHENIA-GRAVIS AND PREECLAMPSIA
    BENSHUSHAN, A
    ROJANSKY, N
    WEINSTEIN, D
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1994, 30 (03): : 229 - 233
  • [46] COPING WITH MYASTHENIA-GRAVIS
    DOERING, S
    HENZE, T
    SCHUSSLER, G
    NERVENARZT, 1993, 64 (10): : 640 - 647
  • [47] IDIOTYPES IN MYASTHENIA-GRAVIS
    LEFVERT, AK
    ADVANCES IN NEUROIMMUNOLOGY, 1994, 4 (04): : 447 - 456
  • [48] Clinical Measurement of Antibodies against Acetylcholine Receptor(AchR),SOD and LPO in Patients with Myasthenia Gravis(MG) be
    潘铁成
    杨明山
    曹学兵
    葛酉新
    张本固
    赵金平
    陈夏丰
    同济医科大学学报(外文版), 1994, (04) : 249 - 251
  • [49] Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor
    Maggi, Lorenzo
    Andreetta, Francesca
    Antozzi, Carlo
    Confalonieri, Paolo
    Cornelio, Ferdinando
    Scaioli, Vidmer
    Mantegazza, Renato
    NEUROMUSCULAR DISORDERS, 2008, 18 (08) : 678 - 680
  • [50] Acetylcholine receptor antibodies in myasthenia gravis are associated with greater risk of diabetes and thyroid disease
    Toth, C.
    McDonald, D.
    Oger, J.
    Brownell, K.
    ACTA NEUROLOGICA SCANDINAVICA, 2006, 114 (02): : 124 - 132